|[April 04, 2014]
50-Year Retrospective Study Shows On-X Life Technologies' Mechanical Heart Valves Have "the Lowest Incidence of Valve Thrombosis"
AUSTIN, Texas --(Business Wire)--
Privately held On-X®
Life Technologies Inc., whose mechanical heart valves have been
implanted in more than 150,000 patients in over 90 countries, announced
today that results from an independent, 50-year retrospective study show
that On-X mechanical heart valves have "the lowest incidence of valve
thrombosis" among the eight different valves that were studied.
The study results ("Valve Thrombosis, Pannus and Mechanical Valve
Design: A 50-Year Learning Curve") were presented from the podium at
"ASCVTS'14" in Istanbul, Turkey, by Mervyn A. Williams, M.D., Provincial
Hospital, Port Elizabeth, South Africa. Data relating to 7,300 valves
used in five healthcare institutions between 1963 and 2013 were
reviewed, and eight different valves were studied. The patients came
from poorly anticoagulated communities where thrombotic complications
were common, thus unmasking the true potential for thrombosis.
"These robust, longterm data fortify the fact that the On-X aortic
valves are unique among all other mechanical heart valves. On-X heart
valves are the result of a breakthrough in medical-grade carbon
technology, which we call On-X pure pyrolytic carbon. In addition to
providing a more thromboresistant surface, the comparatively high
strength of pure On-X carbon has enabled On-X LTI to make significant
valve design changes that have resulted in a prosthesis that acts more
like a natural valve in its treatment of blood," said Clyde Baker,
CEO of On-X Life Technologies.
Clinical studies have documented that On-X valves do not produce the
turbulence and blood damage commonly produced by other mechanical heart
valve prostheses and, therefore, significantly reduce the potential for
life-threatening blood clots.
On-X® Life Technologies (On-X LTI)
On-X Life Technologies (On-X LTI) develops mechanical heart valve
replacements that are designed to dramatically improve the quality of
life of patients. Headquartered in Austin, Texas, On-X LTI is a
privately held company. More information is located at www.onxlti.com.
On-X is a registered trademark of On-X Life Technologies Inc. All other
trademarks mentioned herein belong to their respective companies.
On-X aortic and mitral mechanical heart valves are FDA-approved.
CAUTION: Federal law restricts this device to sale by or on the order of
a physician. Refer to the Instructions for Use that accompany each valve
for indications, contraindications, warnings, precautions and possible
For further information, visit www.onxlti.com.
[ Back To TMCnet.com's Homepage ]